<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Flaherty, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 21, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H574550203"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nonspecific interstitial pneumonia (NSIP) is one type of idiopathic interstitial pneumonia (IIP). The other IIPs include usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), acute interstitial pneumonia (AIP), lymphocytic interstitial pneumonia (LIP), and cryptogenic organizing pneumonia (COP)  (<a class="graphic graphic_table graphicRef95445" href="/z/d/graphic/95445.html" rel="external">table 1</a>) [<a href="#rid1">1</a>].</p><p>NSIP can be idiopathic or can be seen in association with HIV (human immunodeficiency virus) infection, connective tissue diseases, a variety of drugs, and hypersensitivity pneumonitis. It can also present in combination with the other IIPs.</p><p>The etiology, pathogenesis, clinical manifestations, and diagnosis of NSIP will be reviewed here. The treatment and prognosis of NSIP, and the pathology, clinical manifestations, diagnosis, and treatment of the other IIPs are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a> and  <a class="medical medical_review" href="/z/d/html/14870.html" rel="external">"Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis"</a> and  <a class="medical medical_review" href="/z/d/html/4328.html" rel="external">"Treatment of idiopathic pulmonary fibrosis"</a> and  <a class="medical medical_review" href="/z/d/html/4319.html" rel="external">"Respiratory bronchiolitis-associated interstitial lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/4332.html" rel="external">"Cryptogenic organizing pneumonia"</a> and  <a class="medical medical_review" href="/z/d/html/4369.html" rel="external">"Acute interstitial pneumonia (Hamman-Rich syndrome)"</a>.)</p><p class="headingAnchor" id="H376211228"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>Nonspecific interstitial pneumonia (NSIP) is a chronic interstitial pneumonia (IIP) that is called "nonspecific" because it lacks the histopathologic features that characterize usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), or acute interstitial pneumonia (AIP). The histopathology of NSIP is characterized by a homogeneous appearance of dense or loose interstitial fibrosis with mild to moderate chronic interstitial inflammation  (<a class="graphic graphic_table graphicRef81034" href="/z/d/graphic/81034.html" rel="external">table 2</a>) and rare or absent fibroblast foci, dense alveolar septal fibrosis, organizing pneumonia, granulomas, conspicuous infiltration of lymphocytes or eosinophils, and temporal heterogeneity, which are features of other chronic interstitial pneumonias.</p><p class="headingAnchor" id="H3851748293"><span class="h1">CAUSES</span><span class="headingEndMark"> — </span>NSIP can be idiopathic; it has also been associated with many medical conditions, although the specific causal link has not been identified. </p><p class="headingAnchor" id="H1892991025"><span class="h2">Connective tissue disease</span><span class="headingEndMark"> — </span>NSIP is a common pattern in patients with interstitial lung disease (ILD) that arises in the context of connective tissue disease (CTD, also referred to as systemic rheumatic disease), including polymyositis-dermatomyositis, rheumatoid arthritis, Sjögren's disease, and systemic sclerosis (scleroderma) [<a href="#rid2">2-11</a>]. Of note, the exact ILD histopathology is not always known in patients with CTD, as a lung biopsy is not always obtained. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polymyositis-dermatomyositis</strong> – In an observational study of 70 patients with polymyositis-dermatomyositis (PD-DM) and ILD, the most common pulmonary presentation was presumed acute or subacute antibiotic resistant community acquired pneumonia [<a href="#rid5">5</a>]. NSIP was identified in 18 of 22 patients (81 percent) who underwent lung biopsy. (See  <a class="medical medical_review" href="/z/d/html/4304.html" rel="external">"Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rheumatoid arthritis</strong> – NSIP is less common than usual interstitial pneumonitis among patients with rheumatoid arthritis (RA) [<a href="#rid10">10,12</a>]. Among 96 patients with RA and ILD, HRCT interpretation found definite UIP in 21 percent, probable UIP in 20 percent, indeterminate for UIP in 30 percent, NSIP in 14 percent, and an alternative diagnosis in 15 percent [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/4362.html" rel="external">"Interstitial lung disease in rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sjögren's disease</strong> – NSIP is the most frequent histopathologic pattern in patients with ILD and Sjögren's disease (close to 50 percent) [<a href="#rid9">9,13</a>]. (See  <a class="medical medical_review" href="/z/d/html/4301.html" rel="external">"Interstitial lung disease associated with Sjögren's disease: Clinical manifestations, evaluation, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic sclerosis</strong> – NSIP is the most common ILD pattern in patients with systemic sclerosis [<a href="#rid7">7,8,14,15</a>]. Among 80 patients with ILD associated with systemic sclerosis, NSIP was identified in 62 (78 percent) [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/4377.html" rel="external">"Overview of pulmonary complications of systemic sclerosis (scleroderma)"</a>.)</p><p></p><p class="bulletIndent1">Systemic sclerosis sine scleroderma (a rare illness characterized by the typical vascular features and visceral fibrosis of systemic sclerosis but without skin sclerosis) can present with dyspnea with radiographic features of NSIP or UIP [<a href="#rid16">16</a>]. Patients usually have subtle physical exam findings such as scattered telangiectasia, Raynaud's phenomenon, esophageal reflux, pericardial effusion, and abnormal nailfold capillaroscopy. Antinuclear antibodies are typically of the nucleolar pattern. (See  <a class="medical medical_review" href="/z/d/html/7539.html" rel="external">"Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults", section on 'Systemic sclerosis sine scleroderma'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ANCA-associated vasculitis</strong> – NSIP is described in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (often microscopic polyangiitis), although a pattern of usual interstitial pneumonia is more common [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement", section on 'Interstitial lung disease'</a>.)</p><p></p><p class="headingAnchor" id="H718396560"><span class="h2">Interstitial pneumonia with autoimmune features</span><span class="headingEndMark"> — </span>Some patients with idiopathic interstitial pneumonia on lung biopsy (eg, NSIP, UIP/IPF) have features of autoimmune disease, but the findings are insufficient for definitive diagnosis of a specific CTD [<a href="#rid11">11,18,19</a>]. A multidisciplinary task force has proposed criteria for this entity, under the name "interstitial pneumonia with autoimmune features (IPAF)" [<a href="#rid19">19</a>]. IPAF is not considered a diagnosis, but a way of unifying patients with these characteristics for clinical research. Several terms had previously been used to describe these patients, including undifferentiated CTD-ILD, lung-dominant CTD, and autoimmune-featured ILD. The preference for the term "autoimmune features" over "undifferentiated CTD" is that the latter has the connotation of a defined disease, while "autoimmune features" describes the possibility of an underlying autoimmune process centered on the lung.</p><p>Proposed criteria for IPAF are organized around three domains: a clinical domain composed of extrapulmonary clinical features, a serologic domain of specific autoantibodies, and a morphologic domain that includes pulmonary physiologic, chest imaging, and histopathologic features  (<a class="graphic graphic_table graphicRef114388" href="/z/d/graphic/114388.html" rel="external">table 3</a>) [<a href="#rid19">19</a>]. To meet criteria for IPAF, a patient must manifest at least one feature from at least two domains.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Distal digital fissuring or tip ulceration, unexplained digital edema, inflammatory arthritis or polyarticular morning stiffness ≥60 minutes, palmar telangiectasia, Raynaud phenomenon, unexplained rash on the extensor surfaces of digits (Gottron sign).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serologic features</strong> – Antinuclear antibody (ANA) ≥1:320 (diffuse, speckled, homogeneous), ANA any titer with a nucleolar pattern, ANA any titer with a centromere pattern; rheumatoid factor ≥2 times upper limit of normal; antibodies to cyclic citrullinated peptide (anti-CCP), double-stranded (ds) DNA, Ro (SS-A), La (SS-B), ribonucleoprotein (RNP), Smith, topoisomerase (Scl-70), tRNA synthetase (eg, Jo-1, PL-7, PL-12), PM-Scl, or melanoma differentiation-associated gene 5 (MDA-5).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Morphologic features</strong> – Morphologic features include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High-resolution computed tomography (HRCT) appearance suggestive of NSIP or other idiopathic interstitial pneumonia (IIP)  (<a class="graphic graphic_table graphicRef60070" href="/z/d/graphic/60070.html" rel="external">table 4</a>). (See <a class="local">'Chest imaging studies'</a> below.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Histopathologic patterns or features of NSIP or another IIP. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multicompartment involvement such as unexplained pleural thickening or effusion, unexplained pericardial thickening or effusion, unexplained intrinsic airways disease (by pulmonary function testing, HRCT, or pathology), and unexplained pulmonary vasculopathy.</p><p></p><p>Several studies have noted that a high portion of patients with NSIP have underlying features suggestive of CTD [<a href="#rid18">18,20-22</a>]. In a case-control study of 28 patients with NSIP who had no clear underlying disease, 88 percent had laboratory or clinical features of undifferentiated connective tissue disease (autoimmune features) [<a href="#rid18">18</a>]. These features included arthralgias, gastroesophageal reflux disease (GERD), Raynaud's, sicca symptoms, and dysphagia, in addition to positive serologic studies (eg, rheumatoid factor, ANA, or antibodies to SSA, SSB, RNP, Jo-1, Scl-70). A larger study with prospectively collected data is needed to better define the relationship between "idiopathic" and "connective tissue disease-related" NSIP. (See  <a class="medical medical_review" href="/z/d/html/1831.html" rel="external">"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes"</a>.)</p><p class="headingAnchor" id="H2503604539"><span class="h2">Hypersensitivity pneumonitis</span><span class="headingEndMark"> — </span>In some patients with hypersensitivity pneumonitis (also called extrinsic allergic alveolitis), surgical lung biopsy lacks the characteristic poorly formed granulomata and multinucleated giant cells and has an appearance more typical of NSIP [<a href="#rid23">23</a>]. In patients with chronic bird fancier's lung, 13 of 26 had NSIP; most had some multinucleated giant cells, but only one-fourth had granulomas [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H3012476285"><span class="h2">Drug-associated NSIP</span><span class="headingEndMark"> — </span>Many drugs, including but not limited to <a class="drug drug_general" data-topicid="8449" href="/z/d/drug information/8449.html" rel="external">flecainide</a>, <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">amiodarone</a>, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, <a class="drug drug_general" data-topicid="9206" href="/z/d/drug information/9206.html" rel="external">carmustine</a>, <a class="drug drug_general" data-topicid="9704" href="/z/d/drug information/9704.html" rel="external">nitrofurantoin</a>, statins, and <a class="drug drug_general" data-topicid="9240" href="/z/d/drug information/9240.html" rel="external">chlorambucil</a> have been associated with an NSIP pattern [<a href="#rid25">25-31</a>].</p><p class="headingAnchor" id="H1897934785"><span class="h2">HIV infection</span><span class="headingEndMark"> — </span>NSIP is less frequently identified in patients with HIV-infection since the widespread use of antiretroviral therapy (ART), but still occurs [<a href="#rid32">32,33</a>]. In one observational study of 110 patients with AIDS and interstitial lung disease, NSIP was detected in 38 percent [<a href="#rid34">34</a>]. A study performed since the introduction of ART found that 7 percent of HIV patients admitted with ILD had NSIP [<a href="#rid35">35</a>]. Nearly half of these patients had normal chest radiographs. </p><p class="headingAnchor" id="H500393872"><span class="h2">Other</span><span class="headingEndMark"> — </span>NSIP has also been associated with immunoglobulin G4 (IgG4)-related systemic disease [<a href="#rid36">36,37</a>], familial interstitial pneumonia [<a href="#rid38">38,39</a>], and graft versus host disease (GVHD) [<a href="#rid40">40</a>]. Cigarette smoking may also be a factor [<a href="#rid41">41-43</a>]. (See  <a class="medical medical_review" href="/z/d/html/3548.html" rel="external">"Clinical manifestations and diagnosis of chronic graft-versus-host disease"</a>.) </p><p class="headingAnchor" id="H2750300270"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The understanding of the pathogenesis of idiopathic NSIP and other idiopathic interstitial pneumonias (IIPs) is evolving. A potential relationship between NSIP and usual interstitial pneumonia (UIP) is suggested by the commonality of associated diseases, exposures (eg. cigarette smoking), and genetic mutations, in addition to the observation that individual patients can harbor histopathologic lesions of both UIP and NSIP [<a href="#rid44">44,45</a>]. The exact nature of this association is not known. </p><p>Potential contributors to the development and perpetuation of NSIP include epithelial injury and disregulated repair, involvement of the immune system (based on autoimmune features of idiopathic NSIP and the presence of lymphocytes in alveolar septae and bronchoalveolar lavage), and abnormal fibroblast/myofibroblast function leading to excess deposition of collagen. Some of these processes are discussed in the context of UIP/idiopathic pulmonary fibrosis (IPF). (See  <a class="medical medical_review" href="/z/d/html/4300.html" rel="external">"Pathogenesis of idiopathic pulmonary fibrosis"</a>.)</p><p class="headingAnchor" id="H2603523961"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>NSIP that is not clearly associated with an underlying cause typically occurs in middle-aged females (67 percent) who are never smokers (69 percent) [<a href="#rid46">46</a>]; NSIP associated with connective tissue disease (CTD) has an equal distribution between males and females. As noted above, some patients with NSIP have idiopathic disease, while others have a predisposing underlying disease or exposure. In a given patient, the clinical features can be limited to those attributable to NSIP or may reflect extrapulmonary manifestations of the associated process. As an example, a known CTD may be present, or features suggestive but not diagnostic of CTD may be present. (See <a class="local">'Interstitial pneumonia with autoimmune features'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – The most common symptoms of NSIP are dyspnea and cough that have developed subacutely over weeks to months [<a href="#rid3">3,4,47</a>]. About one-third of patients have fever or flu-like symptoms. Depending on whether an underlying CTD is present, patients may also report dry mouth or eyes, joint pain or swelling, muscle tenderness or weakness, Raynaud phenomenon, rash or other skin changes, or neurologic symptoms.</p><p></p><p class="bulletIndent1">Occasional patients with apparent idiopathic NSIP may develop CTD after the diagnosis of NSIP. In a series of 35 patients initially diagnosed with idiopathic NSIP, 17 percent were subsequently diagnosed with dermatomyositis, Sjögren's disease, or rheumatoid arthritis [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – The majority of patients have bibasilar crackles, but only 10 to 35 percent have clubbing [<a href="#rid49">49</a>]. Careful attention should be paid to identifying stigmata of rheumatic disease. Nail bed capillaroscopy may be helpful if systemic sclerosis is suspected.</p><p></p><p class="headingAnchor" id="H149258156"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>NSIP is typically suspected in patients with subacute onset of dyspnea and cough and radiographic evidence of interstitial lung disease. The assessment of patients with suspected NSIP requires a synthesis of clinical, laboratory, pulmonary function, radiographic, and (sometimes) histopathologic data [<a href="#rid46">46,50</a>]. An important component of the evaluation is determining whether the patient has any predisposing conditions or exposures [<a href="#rid51">51,52</a>]. (See <a class="local">'Definition'</a> above and  <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">"Approach to the adult with interstitial lung disease: Clinical evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">"Approach to the adult with interstitial lung disease: Diagnostic testing"</a> and  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a>.)</p><p>As cigarette smoking is associated with a number of idiopathic interstitial pneumonias (IIPs), patients who smoke should be advised to stop smoking even prior to making a diagnosis.</p><p class="headingAnchor" id="H3681214493"><span class="h2">Clinical review</span><span class="headingEndMark"> — </span>Given the broad differential diagnosis of interstitial lung disease, a detailed history is important to narrow the possibilities. Patients should be asked about exposure to airborne organic antigens (eg, barns, birds, hot tubs, humidifiers, mold, plastic/epoxy manufacture) [<a href="#rid53">53</a>]. A complete list of current and recent medications should be reviewed for agents associated with NSIP; patients should be asked about any history of radiation therapy; and risk factors for HIV infection should be assessed. (See  <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">"Approach to the adult with interstitial lung disease: Clinical evaluation", section on 'History'</a> and <a class="local">'Drug-associated NSIP'</a> above.)</p><p>As with any patient being evaluated for interstitial lung disease, nonpulmonary symptoms and signs should be assessed, as described in the table  (<a class="graphic graphic_table graphicRef73094" href="/z/d/graphic/73094.html" rel="external">table 5</a>) [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H704214432"><span class="h2">Laboratory tests</span><span class="headingEndMark"> — </span>No laboratory tests are specific for NSIP. However, in the evaluation of patients with dyspnea, cough, and pulmonary radiographic opacities, the usual laboratory tests include a complete blood count and differential, blood urea nitrogen, creatinine, hepatic function tests, brain natriuretic peptide, and urinalysis  (<a class="graphic graphic_table graphicRef105280" href="/z/d/graphic/105280.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">"Approach to the adult with interstitial lung disease: Diagnostic testing"</a>.)</p><p>For patients without a known CTD, we typically obtain an antinuclear antibody, rheumatoid factor, and anti-citrullinated peptide antibodies, early in the course of the evaluation of ILD. If a systemic rheumatic disease is suspected on the basis of extrathoracic symptoms or signs, we also obtain serologic testing appropriate to those findings  (<a class="graphic graphic_table graphicRef105280" href="/z/d/graphic/105280.html" rel="external">table 6</a>) [<a href="#rid18">18,54,55</a>]. A broader panel of serologic tests is obtained, as needed, based on results of initial testing and after a diagnosis of NSIP has been made.</p><p>The utility of screening panels for hypersensitivity pneumonitis (HP) is unclear due to problems with specificity. We typically reserve serologic testing for HP for patients with a historical risk factor (eg, occupational or environmental exposures). (See  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis", section on 'Laboratory tests'</a>.)</p><p>Testing for HIV infection should be performed unless it can be excluded on the basis of clinical history [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p class="headingAnchor" id="H4041760834"><span class="h2">Pulmonary function tests</span><span class="headingEndMark"> — </span>Pulmonary function tests (PFTs) are obtained in most ambulatory adults with dyspnea and cough to determine whether the symptoms are associated with an obstructive or restrictive impairment and whether a gas transfer defect is present. Generally, testing includes spirometry, lung volumes, diffusing capacity for carbon monoxide (DLCO), and a six-minute walk test with assessment of oxygen saturation. While pulmonary function testing is not essential for making the diagnosis of NSIP, monitoring forced vital capacity (FVC) and DLCO is helpful for assessing baseline respiratory impairment, disease progression, response to therapy, and prognosis [<a href="#rid56">56</a>].</p><p>In patients with NSIP, PFTs typically demonstrate a restrictive ventilatory defect (decreased FVC and total lung capacity [TLC]) and impaired gas transfer manifested by a decrease in DLCO and/or desaturation during ambulatory oximetry [<a href="#rid53">53</a>]. Mild resting hypoxemia may be present at diagnosis [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults"</a>.)</p><p class="headingAnchor" id="H4070053323"><span class="h2">Chest imaging studies</span><span class="headingEndMark"> — </span>A chest radiograph is obtained in virtually all adults with persistent symptoms of dyspnea and cough, particularly in the presence of fever. High-resolution computed tomography (HRCT) scans should be obtained in all patients suspected of having NSIP on the basis of an abnormal conventional chest radiograph or impaired gas transfer. In addition to aiding the diagnosis, serial HRCT scans may be useful to assess disease improvement or progression [<a href="#rid57">57-62</a>]. (See  <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – Chest radiographs of NSIP typically show bilaterally increased markings with a basilar predominance [<a href="#rid63">63</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High-resolution computed tomography</strong> – HRCT scans should be noncontrast with images obtained at full inspiration, unless expiratory views are needed to look for areas of air trapping (eg, in hypersensitivity pneumonitis). Prone views are often obtained in addition to supine to make sure that dependent atelectasis is not mistaken for interstitial disease.</p><p></p><p class="bulletIndent1">The most frequent HRCT findings in NSIP are increased reticular markings (87 percent), traction bronchiectasis (82 percent), lobar volume loss (77 percent), and ground glass opacification (GGO, 42 percent), predominantly in the lower lung zones (92 percent) [<a href="#rid46">46,64</a>]. Other studies have found GGO in up to 94 percent of NSIP [<a href="#rid65">65</a>]. Bibasilar GGO that spares the subpleural region is the most characteristic HRCT appearance in NSIP, but is not pathognomonic and was only observed in 21 percent of one series [<a href="#rid65">65</a>]. When present, it is often associated with manifestations of fibrosis such as volume loss, reticular pattern, and/or traction bronchiectasis. </p><p></p><p class="bulletIndent1">The HRCT features of idiopathic NSIP compared to CTD-related NSIP are similar [<a href="#rid2">2-4,9,23,47,57-61,66-76</a>].</p><p></p><p class="bulletIndent1">Honeycomb change is rare with NSIP; a predominance of honeycombing relative to ground glass attenuation suggests UIP [<a href="#rid77">77-79</a>]. </p><p></p><p class="bulletIndent1">Unlike UIP/IPF where HRCT can at times supplant the need for a surgical lung biopsy, the ability of HRCT to make an accurate diagnosis of NSIP is more limited [<a href="#rid80">80</a>]. This is in part related to variable inter-reader interpretations of HRCT [<a href="#rid81">81</a>]. Several series have evaluated the ability of HRCT to make a diagnosis of NSIP (as confirmed by surgical lung biopsy). The accuracy ranges from 66 to 68 percent [<a href="#rid71">71,79</a>]. </p><p></p><p class="headingAnchor" id="H2152164648"><span class="h2">Bronchoalveolar lavage</span><span class="headingEndMark"> — </span>Bronchoalveolar lavage (BAL) findings in NSIP are nonspecific, and BAL cell counts cannot be utilized to differentiate NSIP from other IIPs [<a href="#rid82">82</a>]. The main role of BAL in patients with imaging findings suggestive of NSIP is to exclude other causes of diffuse opacities, such as hemorrhage, infection and malignancy. As a result, BAL is not typically used for the evaluation of suspected IIP unless hypersensitivity pneumonitis, malignancy, or opportunistic infection is likely. (See  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"</a>.)</p><p>In some reports, a higher percentage of lymphocytes was noted in bronchoalveolar lavage (BAL) from patients with NSIP compared with UIP [<a href="#rid3">3,4,47,66</a>]; however, this is not always the case [<a href="#rid67">67,82</a>]. In addition, several other ILDs have BAL lymphocytosis, making this a nonspecific finding. (See  <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease", section on 'Lymphocytic BAL'</a>.) </p><p class="headingAnchor" id="H2580944988"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>A definitive diagnosis of NSIP requires histopathologic analysis of a surgical lung biopsy specimen, accompanied by a multidisciplinary assessment when possible [<a href="#rid52">52,54</a>]. However, a surgical lung biopsy is not always needed to guide management. The need for a surgical lung biopsy to confirm the diagnosis of NSIP largely depends on the presence or absence of an underlying process known to be associated with NSIP and the severity of lung disease. </p><p class="headingAnchor" id="H708224181"><span class="h2">Clinical diagnosis based on multidisciplinary discussion (MDD)</span><span class="headingEndMark"> — </span>Often a confident clinical diagnosis can be achieved through a MMD that reviews the clinical findings, evidence of associated diseases or exposures, laboratory data, and high-resolution computed tomography (HRCT) features. MDD is helpful to optimize diagnostic accuracy and ensure that subtle clinical and morphologic features and potential inciting drugs and exposures are not overlooked. </p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a known connective tissue disease (CTD) and a clinical course and HRCT pattern consistent with NSIP generally do not need a lung biopsy. (See  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease", section on 'Interstitial lung disease associated with systemic rheumatic disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If drug-induced NSIP is suspected (eg, <a class="drug drug_general" data-topicid="9704" href="/z/d/drug information/9704.html" rel="external">nitrofurantoin</a>, <a class="drug drug_general" data-topicid="8449" href="/z/d/drug information/8449.html" rel="external">flecainide</a>, <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">amiodarone</a>, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, <a class="drug drug_general" data-topicid="9206" href="/z/d/drug information/9206.html" rel="external">carmustine</a>, statins), the culprit drug should be discontinued and lung biopsy deferred pending the response to drug discontinuation. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with exposure to agents associated with hypersensitivity pneumonitis (HP) should be evaluated with directed serologic tests, examination of HRCT for features of HP  (<a class="graphic graphic_table graphicRef119874" href="/z/d/graphic/119874.html" rel="external">table 7</a>), and a trial of exposure avoidance (if feasible). Flexible bronchoscopy may be helpful if bronchoalveolar lavage fluid is lymphocytic (&gt;20 percent), particularly if the CD4/CD8 lymphocyte ratio is &lt;1. If confident exclusion of HP is not possible noninvasively, a lung biopsy (transbronchial, surgical) is often needed. (See  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3352358036"><span class="h2">Surgical lung biopsy</span><span class="headingEndMark"> — </span>When a confident clinical diagnosis remains unclear after MDD, the decision to proceed with surgical lung biopsy often depends on the severity of lung disease. Patients with mild respiratory impairment may prefer to wait for evidence of progression prior to lung biopsy. At the other end of the spectrum for patients with severe respiratory impairment, the benefits of a secure diagnosis need to be carefully weighed against the risks of surgical biopsy in the patients with severe respiratory impairment. (See  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a>.)</p><p>For definitive diagnosis of diffuse interstitial lung disease, surgical lung biopsy via VATS or thoracotomy is the standard; transbronchial cryobiopsy (cryo-TBB) is gaining acceptance, but is not considered to be a replacement for surgical lung biopsy. Transbronchial lung biopsy (TBLB) has a low diagnostic yield in the IIPs and is generally avoided when NSIP is suspected. (See  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a>.)</p><p>Ideally, when evaluating interstitial lung disease, surgical samples are obtained from more than one lobe and are greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm. (See  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease", section on 'Specimen collection'</a>.)</p><p class="headingAnchor" id="H420529916"><span class="h2">Histopathology and interpretation</span><span class="headingEndMark"> — </span>Histopathologic examination by an experienced lung pathologist is essential, and most cases require careful clinical and pathological correlation to arrive at the most accurate final diagnosis [<a href="#rid83">83-85</a>]. Although the histopathologic features of NSIP are well defined, the differentiation of NSIP from other IIPs, particularly idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP), is difficult and even expert pathologists may disagree on a particular biopsy [<a href="#rid86">86,87</a>]. (See  <a class="medical medical_review" href="/z/d/html/4379.html" rel="external">"Role of lung biopsy in the diagnosis of interstitial lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">"Interpretation of lung biopsy results in interstitial lung disease"</a>.)</p><p>The histopathology of NSIP is characterized by the following features  (<a class="graphic graphic_picture graphicRef75438 graphicRef58583" href="/z/d/graphic/75438.html" rel="external">picture 1A-B</a> and <a class="graphic graphic_table graphicRef81034" href="/z/d/graphic/81034.html" rel="external">table 2</a>) [<a href="#rid1">1,53</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse alveolar wall thickening by uniform fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Preservation of the alveolar architecture when examined with elastin stains</p><p class="bulletIndent1"><span class="glyph">●</span>Expansion of alveolar septa by variably dense infiltrate of predominantly mononuclear inflammatory </p><p class="bulletIndent1"><span class="glyph">●</span>Overall pattern suggests temporal homogeneity </p><p></p><p>The histopathologic features do not fit the patterns of other IIPs such as UIP, desquamative interstitial pneumonia, respiratory bronchiolitis interstitial lung disease, cryptogenic organizing pneumonia, acute interstitial pneumonia, or lymphocytic interstitial pneumonia. While a few fibroblast foci and focal areas of organizing pneumonia may be present in NSIP, dense alveolar septal fibrosis, granulomas, conspicuous infiltration of lymphocytes or eosinophils, and temporal heterogeneity are absent. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Nonspecific interstitial pneumonia'</a>.)</p><p>NSIP was initially divided into three groups, based upon the presence and extent of interstitial fibrosis: Group I with primarily interstitial inflammation  (<a class="graphic graphic_picture graphicRef75438" href="/z/d/graphic/75438.html" rel="external">picture 1A</a>), Group II with both inflammation and fibrosis, and Group III with primarily fibrosis  (<a class="graphic graphic_picture graphicRef58583" href="/z/d/graphic/58583.html" rel="external">picture 1B</a>). Group III is distinguished from UIP by the absence of fibroblast foci and the presence of temporal homogeneity [<a href="#rid2">2</a>]. However, later studies found no prognostic difference between Groups II and III, so the subgroups were merged into two, cellular and fibrotic. (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology", section on 'Pathology'</a>.) </p><p>The classification of NSIP is further complicated by the fact that areas of both NSIP and UIP can be identified in the same patient when biopsies are taken from multiple locations. Studies evaluating patients with multiple lobe biopsies found a pattern of UIP in one lobe and NSIP in another lobe in 13 to 26 percent of patients [<a href="#rid44">44,45</a>]. These mixed NSIP/UIP cases had a similar prognosis to patients with UIP/IPF in all lobes.</p><p class="headingAnchor" id="H2272739239"><span class="h2">Interstitial pneumonia with autoimmune features</span><span class="headingEndMark"> — </span>Part of the role of interdisciplinary assessment is to determine whether NSIP is associated with an underlying CTD. In this process, some patients will be identified who do not meet criteria for a specific CTD, but have some subtle "autoimmune" features. An international consensus task force has proposed classifying such patients as having "interstitial pneumonia with autoimmune features" [<a href="#rid19">19</a>]. (See <a class="local">'Interstitial pneumonia with autoimmune features'</a> above.)</p><p>If not already performed, the serologic testing outlined in the table can help identify patients with IPAF  (<a class="graphic graphic_table graphicRef114388" href="/z/d/graphic/114388.html" rel="external">table 3</a>). (See <a class="local">'Interstitial pneumonia with autoimmune features'</a> above.)</p><p class="headingAnchor" id="H572240318"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of NSIP includes the other idiopathic interstitial pneumonias (IIPs), other diseases with histopathologic features of NSIP, such as rheumatic diseases (eg, rheumatoid arthritis, systemic sclerosis), chronic hypersensitivity pneumonitis, asbestosis, and certain drug-induced lung diseases.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other idiopathic interstitial pneumonias</strong> – Usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF) is the IIP that has the greatest overlap with NSIP. The imaging findings and histopathology of UIP/IPF and the differentiating features of the various IIPs are discussed separately  (<a class="graphic graphic_table graphicRef60070" href="/z/d/graphic/60070.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">"Idiopathic interstitial pneumonias: Classification and pathology"</a> and  <a class="medical medical_review" href="/z/d/html/14870.html" rel="external">"Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis", section on 'Histopathology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypersensitivity pneumonitis</strong> – Certain imaging features help to differentiate hypersensitivity pneumonitis (HP) from NSIP. High-resolution computed tomography (HRCT) findings of centrilobular nodules, mosaic air-trapping, and upper lung zone distribution suggest HP rather than NSIP [<a href="#rid1">1,64</a>]. On histopathology, bronchiolocentric distribution of mononuclear and giant cell inflammation and poorly formed granulomas suggest HP. (See  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunoglobulin G4 (IgG4)-related systemic disease – </strong>A portion of patients with IgG4-related systemic disease have interstitial lung disease [<a href="#rid36">36,37</a>]. While some features are similar to NSIP, histopathology demonstrates infiltration of the lung interstitium with IgG4-positive plasma cells.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Familial interstitial pneumonia</strong> – Among patients with familial interstitial pneumonia (FIP), a small portion have HRCT and histopathologic features consistent with NSIP, while the majority have features of UIP/IPF [<a href="#rid38">38</a>]. In a study of HRCT characteristics of FIP, patients with FIP were more likely to have a diffuse craniocaudal distribution of opacities, whether reticular or mixed reticular-ground glass, while UIP/IPF and NSIP are typically basilar predominant [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/4300.html" rel="external">"Pathogenesis of idiopathic pulmonary fibrosis", section on 'Genetic predisposition'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hermansky-Pudlak syndrome</strong> – Hermansky-Pudlak syndrome is a rare genetic defect associated with oculocutaneous albinism, abnormal platelets, and fibrotic interstitial lung disease. While the lung disease is similar to UIP/IPF in most patients, some patients have features more typical of NSIP, such as onset at an earlier age (eg, thirties) reticular and ground glass opacities on HRCT, and on histopathology, temporal homogeneity, sparse mononuclear cell infiltration, and diffuse collagen deposition [<a href="#rid88">88</a>]. Foamy swelling of type II pneumocytes is a clue to the underlying HPS. (See  <a class="medical medical_review" href="/z/d/html/115158.html" rel="external">"Hermansky-Pudlak syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H2983641713"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118793.html" rel="external">"Society guideline links: Interstitial lung disease"</a>.)</p><p class="headingAnchor" id="H1594353254"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions</strong> – Nonspecific interstitial pneumonia (NSIP) is one type of idiopathic interstitial pneumonia (IIP)  (<a class="graphic graphic_table graphicRef95445" href="/z/d/graphic/95445.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathology</strong> – The histopathologic lesion characteristic of NSIP is thickening of the alveolar septum with varying degrees of inflammatory (mononuclear) cell infiltration and fibrosis in a pattern suggesting temporal homogeneity. The fibroblast foci and temporal heterogeneity typical of usual interstitial pneumonia (UIP) are rarely seen. (See <a class="local">'Histopathology and interpretation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – NSIP may be idiopathic or may be associated with connective tissue disease (CTD), certain drugs, human immunodeficiency virus infection, and hypersensitivity pneumonitis. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The onset of idiopathic NSIP is typically in the fifth or sixth decades of life, with both sexes affected equally. Most patients present with the insidious onset of dyspnea and cough. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory studies</strong> – Laboratory testing is similar to that of other patients with suspected ILD  (<a class="graphic graphic_table graphicRef105280" href="/z/d/graphic/105280.html" rel="external">table 6</a>). For patients with radiographically suspected or histologically determined NSIP without a known CTD, we typically obtain an antinuclear antibody, rheumatoid factor, and anticitrullinated peptide antibodies early in the course of the evaluation. Additional serologic testing is guided by extrathoracic symptoms or signs and results of initial testing. (See <a class="local">'Laboratory tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pulmonary function testing (PFTs)</strong> – PFTs generally include spirometry, lung volumes, diffusing capacity for carbon monoxide (DLCO), and a six-minute walk test with oximetry. NSIP is typically associated with a restrictive ventilatory defect and a low diffusing capacity with or without exertional oxygen desaturation. (See <a class="local">'Pulmonary function tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chest imaging</strong> – Bibasilar diffuse ground glass or reticular opacities are typical findings on chest radiograph. High-resolution computed tomography (HRCT) usually shows ground glass and reticular opacities, predominantly in the lower lung zones. Traction bronchiectasis and lobar volume loss may be present, but honeycombing is generally absent. (See <a class="local">'Chest imaging studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients with connective tissue disease or HIV</strong> – For patients with known underlying connective tissue disease or HIV infection AND HRCT findings consistent with NSIP, histopathologic confirmation of NSIP is generally not necessary. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other patients</strong> – For most patients without an underlying process known to be associated with NSIP, lung biopsy obtained by thoracoscopy or thoracotomy and multidisciplinary clinicopathologic correlation are needed to confirm a diagnosis of NSIP. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2">For patients with confirmed or radiographically suspected NSIP, every effort should be made to identify any exposure or concomitant systemic disease that may be contributory. (See <a class="local">'Histopathology and interpretation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of NSIP includes the other IIPs  (<a class="graphic graphic_table graphicRef95445" href="/z/d/graphic/95445.html" rel="external">table 1</a>), chronic hypersensitivity pneumonitis, asbestosis, and certain drug-induced lung diseases. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733.</a></li><li><a class="nounderline abstract_t">Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18:136.</a></li><li><a class="nounderline abstract_t">Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998; 158:1286.</a></li><li><a class="nounderline abstract_t">Fujita J, Yamadori I, Suemitsu I, et al. Clinical features of non-specific interstitial pneumonia. Respir Med 1999; 93:113.</a></li><li><a class="nounderline abstract_t">Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164:1182.</a></li><li><a class="nounderline abstract_t">Miki H, Mio T, Nagai S, et al. Fibroblast contractility: usual interstitial pneumonia and nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2000; 162:2259.</a></li><li><a class="nounderline abstract_t">Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165:1581.</a></li><li><a class="nounderline abstract_t">Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19:121.</a></li><li><a class="nounderline abstract_t">Yamadori I, Fujita J, Bandoh S, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002; 22:89.</a></li><li><a class="nounderline abstract_t">Yoshinouchi T, Ohtsuki Y, Fujita J, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005; 26:121.</a></li><li><a class="nounderline abstract_t">Xu W, Xiao Y, Liu H, et al. Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med 2014; 14:175.</a></li><li><a class="nounderline abstract_t">Yamakawa H, Sato S, Tsumiyama E, et al. Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria. J Thorac Dis 2019; 11:5247.</a></li><li><a class="nounderline abstract_t">Reina D, Roig Vilaseca D, Torrente-Segarra V, et al. Sjögren's syndrome-associated interstitial lung disease: A multicenter study. Reumatol Clin 2016; 12:201.</a></li><li><a class="nounderline abstract_t">Cappelli S, Bellando Randone S, Camiciottoli G, et al. Interstitial lung disease in systemic sclerosis: where do we stand? Eur Respir Rev 2015; 24:411.</a></li><li><a class="nounderline abstract_t">Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232:560.</a></li><li><a class="nounderline abstract_t">Fischer A, Meehan RT, Feghali-Bostwick CA, et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 2006; 130:976.</a></li><li><a class="nounderline abstract_t">Arulkumaran N, Periselneris N, Gaskin G, et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 2011; 50:2035.</a></li><li><a class="nounderline abstract_t">Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007; 176:691.</a></li><li><a class="nounderline abstract_t">Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976.</a></li><li><a class="nounderline abstract_t">Kim HC, Ji W, Kim MY, et al. Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis. Chest 2015; 147:165.</a></li><li><a class="nounderline abstract_t">Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39:661.</a></li><li><a class="nounderline abstract_t">Ahmad K, Barba T, Gamondes D, et al. Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 2017; 123:56.</a></li><li><a class="nounderline abstract_t">Vourlekis JS, Schwarz MI, Cool CD, et al. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002; 112:490.</a></li><li><a class="nounderline abstract_t">Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005; 60:665.</a></li><li><a class="nounderline abstract_t">Pesenti S, Lauque D, Daste G, et al. Diffuse infiltrative lung disease associated with flecainide. Report of two cases. Respiration 2002; 69:182.</a></li><li><a class="nounderline abstract_t">Lantuejoul S, Brambilla E, Brambilla C, Devouassoux G. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J 2002; 19:577.</a></li><li><a class="nounderline abstract_t">Brinker A, Johnston M. Acute pulmonary injury in association with amiodarone. Chest 2004; 125:1591.</a></li><li><a class="nounderline abstract_t">Ridley MG, Wolfe CS, Mathews JA. Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature. Ann Rheum Dis 1988; 47:784.</a></li><li><a class="nounderline abstract_t">Arakawa H, Yamasaki M, Kurihara Y, et al. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18:231.</a></li><li><a class="nounderline abstract_t">Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20:1245.</a></li><li class="breakAll">Pneumotox: The drug-induced respiratory disease website. http://www.pneumotox.com/ (Accessed on June 08, 2017).</li><li><a class="nounderline abstract_t">Doffman SR, Miller RF. Interstitial lung disease in HIV. Clin Chest Med 2013; 34:293.</a></li><li><a class="nounderline abstract_t">George MP, Singh V, Gladwin MT. Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection. Semin Respir Crit Care Med 2016; 37:289.</a></li><li><a class="nounderline abstract_t">Suffredini AF, Ognibene FP, Lack EE, et al. Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 107:7.</a></li><li><a class="nounderline abstract_t">Narayanswami G, Narasimhan M, Rosen M, et al. Pulmonary complications of HIV disease in the era of highly active antiretroviraltherapy (HAART). Chest 2002; 122:34S.</a></li><li><a class="nounderline abstract_t">Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47:291.</a></li><li><a class="nounderline abstract_t">Zhang H, Shi JH, Feng RE, et al. [The clinicopathological analysis of 4 cases of IgG4-related nonspecific interstitial pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2012; 35:747.</a></li><li><a class="nounderline abstract_t">Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172:1146.</a></li><li><a class="nounderline abstract_t">Lee HY, Seo JB, Steele MP, et al. High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia. Chest 2012; 142:1577.</a></li><li><a class="nounderline abstract_t">Uhlving HH, Andersen CB, Christensen IJ, et al. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21:531.</a></li><li><a class="nounderline abstract_t">Marten K, Milne D, Antoniou KM, et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol 2009; 19:1679.</a></li><li><a class="nounderline abstract_t">Shinohara T, Kadota N, Hino H, et al. Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation. Respir Med Case Rep 2015; 14:7.</a></li><li><a class="nounderline abstract_t">Sawata T, Bando M, Nakayama M, et al. Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern. Intern Med 2016; 55:2939.</a></li><li><a class="nounderline abstract_t">Monaghan H, Wells AU, Colby TV, et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125:522.</a></li><li><a class="nounderline abstract_t">Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.</a></li><li><a class="nounderline abstract_t">Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177:1338.</a></li><li><a class="nounderline abstract_t">Park CS, Jeon JW, Park SW, et al. Nonspecific interstitial pneumonia/fibrosis: clinical manifestations, histologic and radiologic features. Korean J Intern Med 1996; 11:122.</a></li><li><a class="nounderline abstract_t">Kono M, Nakamura Y, Yoshimura K, et al. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease. Respir Med 2016; 117:40.</a></li><li><a class="nounderline abstract_t">Flaherty KR, Martinez FJ, Travis W, Lynch JP 3rd. Nonspecific interstitial pneumonia (NSIP). Semin Respir Crit Care Med 2001; 22:423.</a></li><li><a class="nounderline abstract_t">Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170:904.</a></li><li><a class="nounderline abstract_t">Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008; 31:11.</a></li><li><a class="nounderline abstract_t">Belloli EA, Beckford R, Hadley R, Flaherty KR. Idiopathic non-specific interstitial pneumonia. Respirology 2016; 21:259.</a></li><li><a class="nounderline abstract_t">American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277.</a></li><li><a class="nounderline abstract_t">Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5:v1.</a></li><li><a class="nounderline abstract_t">Fujita J, Ohtsuki Y, Yoshinouchi T, et al. Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia". Respir Med 2005; 99:234.</a></li><li><a class="nounderline abstract_t">Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168:531.</a></li><li><a class="nounderline abstract_t">Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195:645.</a></li><li><a class="nounderline abstract_t">Kim EY, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation. AJR Am J Roentgenol 1999; 173:949.</a></li><li><a class="nounderline abstract_t">Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000; 55:854.</a></li><li><a class="nounderline abstract_t">Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003; 123:1096.</a></li><li><a class="nounderline abstract_t">Nishiyama O, Kondoh Y, Taniguchi H, et al. Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J Comput Assist Tomogr 2000; 24:41.</a></li><li><a class="nounderline abstract_t">Akira M, Inoue Y, Arai T, et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66:61.</a></li><li><a class="nounderline abstract_t">Kinder BW. Nonspecific interstitial pneumonia. Clin Chest Med 2012; 33:111.</a></li><li><a class="nounderline abstract_t">Silva CI, Müller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246:288.</a></li><li><a class="nounderline abstract_t">Park IN, Jegal Y, Kim DS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009; 33:68.</a></li><li><a class="nounderline abstract_t">Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12:1010.</a></li><li><a class="nounderline abstract_t">Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160:899.</a></li><li><a class="nounderline abstract_t">Kim TS, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. AJR Am J Roentgenol 1998; 171:1645.</a></li><li><a class="nounderline abstract_t">Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:199.</a></li><li><a class="nounderline abstract_t">Johkoh T, Müller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211:555.</a></li><li><a class="nounderline abstract_t">Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217:701.</a></li><li><a class="nounderline abstract_t">MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221:600.</a></li><li><a class="nounderline abstract_t">Riha RL, Duhig EE, Clarke BE, et al. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 2002; 19:1114.</a></li><li><a class="nounderline abstract_t">Johkoh T, Müller NL, Colby TV, et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225:199.</a></li><li><a class="nounderline abstract_t">Jegal Y, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171:639.</a></li><li><a class="nounderline abstract_t">Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22 Spec No:S151.</a></li><li><a class="nounderline abstract_t">Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19:275.</a></li><li><a class="nounderline abstract_t">Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124:1215.</a></li><li><a class="nounderline abstract_t">Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58:143.</a></li><li><a class="nounderline abstract_t">Silva CI, Müller NL, Hansell DM, et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247:251.</a></li><li><a class="nounderline abstract_t">Aziz ZA, Wells AU, Hansell DM, et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59:506.</a></li><li><a class="nounderline abstract_t">Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003; 22:239.</a></li><li><a class="nounderline abstract_t">Jo HE, Glaspole IN, Levin KC, et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 2016; 21:1438.</a></li><li><a class="nounderline abstract_t">Ferri C, Manfredi A, Sebastiani M, et al. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 2016; 15:61.</a></li><li><a class="nounderline abstract_t">Castelino FV, Goldberg H, Dellaripa PF. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology (Oxford) 2011; 50:489.</a></li><li><a class="nounderline abstract_t">Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59:500.</a></li><li><a class="nounderline abstract_t">Lettieri CJ, Veerappan GR, Parker JM, et al. Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. Respir Med 2005; 99:1425.</a></li><li><a class="nounderline abstract_t">Furuhashi K, Enomoto N, Fujisawa T, et al. Hermansky-Pudlak syndrome with nonspecific interstitial pneumonia. Intern Med 2014; 53:449.</a></li></ol></div><div id="topicVersionRevision">Topic 112195 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24032382" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8291652" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9769293" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10464862" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical features of non-specific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11673206" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Polymyositis-dermatomyositis-associated interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11112149" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Fibroblast contractility: usual interstitial pneumonia and nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12070056" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12108451" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12111081" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15580351" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25380997" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Nonspecific interstitial pneumonia: clinical associations and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32030242" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26573882" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sjögren's syndrome-associated interstitial lung disease: A multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26324802" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Interstitial lung disease in systemic sclerosis: where do we stand?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15286324" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035427" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21873269" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556720" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26160873" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25211168" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21920896" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Significance of connective tissue disease features in idiopathic interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28137497" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11959061" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16061708" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11961436" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Diffuse infiltrative lung disease associated with flecainide. Report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11936540" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Statin-induced fibrotic nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078784" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute pulmonary injury in association with amiodarone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3052323" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14561908" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Methotrexate-induced pulmonary injury: serial CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10992015" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pulmonary drug toxicity: radiologic and pathologic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10992015" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pulmonary drug toxicity: radiologic and pathologic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23702178" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Interstitial lung disease in HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26974305" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3496030" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pulmonary complications of HIV disease in the era of highly active antiretroviraltherapy (HAART)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18277032" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23289991" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : [The clinicopathological analysis of 4 cases of IgG4-related nonspecific interstitial pneumonia].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16109978" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical and pathologic features of familial interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23364926" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25498923" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19214521" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Non-specific interstitial pneumonia in cigarette smokers: a CT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26029566" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27746429" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14769733" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719316" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Histopathologic variability in usual and nonspecific interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18388353" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8854648" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Nonspecific interstitial pneumonia/fibrosis: clinical manifestations, histologic and radiologic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27492512" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16088690" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Nonspecific interstitial pneumonia (NSIP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15256390" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166591" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Occult connective tissue diseases mimicking idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26564810" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Idiopathic non-specific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11790668" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18757459" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15715192" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12791580" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7753988" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10511155" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10992538" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12684299" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10667656" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21071764" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22365250" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18096541" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18829672" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9863989" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10471616" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843306" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9445300" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10228542" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11110931" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11719652" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12108865" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12355005" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15640368" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12376608" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11866008" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Clinical significance of histological classification of idiopathic interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14555549" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12554898" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Radiological versus histological diagnosis in UIP and NSIP: survival implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18270375" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15170034" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12952254" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27427515" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Clinical impact of the interstitial lung disease multidisciplinary service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26384526" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20685802" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The impact of rheumatological evaluation in the management of patients with interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15170033" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Inter-observer variation between pathologists in diffuse parenchymal lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210097" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24583434" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Hermansky-Pudlak syndrome with nonspecific interstitial pneumonia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
